Medicare Enrolled
Dr. Michael Bryant, M.D.
Urology Physician · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bryant from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bryant?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bryant
Dr. Michael Bryant is an urology physician in Marietta, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Bryant performed 2,274 Medicare services across 1,815 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bryant received a total of $4,948 from 48 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bryant is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 37% volume in GA
$4,948 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,274
Medicare services
Top 37% in GA for urology physician
1,815
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~142 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
556 | $2 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
300 | $7 | $67 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
292 | $62 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $92 | $282 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 153 | $130 | $1,028 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
141 | $111 | $376 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
83 | $61 | $632 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
65 | $54 | $255 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
52 | $27 | $143 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $64 | $180 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
40 | $20 | $97 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $130 | $382 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
29 | $15 | $49 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $84 | $250 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
24 | $111 | $1,633 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
21 | $15 | $176 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $102 | $696 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
21 | $3 | $16 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
20 | $24 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $140 | $454 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $79 | $282 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $332 | $1,806 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $96 | $255 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $79 | $296 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $32 | $168 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
11 | $131 | $1,311 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
11 | $41 | $356 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
23.5% medium
74.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,948
Total received (2018-2024)
Avg $707/year across 7 years
Top 46% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,933 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$692
2023
$882
2022
$953
2021
$199
2020
$427
2019
$918
2018
$878
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$189
Sumitomo Pharma America, Inc.
$85
Ferring Pharmaceuticals Inc.
$62
Merck Sharp & Dohme LLC
$61
Edap Technomed Inc
$54
UROGEN PHARMA, INC.
$38
PROCEPT BioRobotics Corporation
$32
Astellas Pharma US Inc
$29
Dendreon Pharmaceuticals LLC
$28
Endo Pharmaceuticals Inc.
$24
Ambu Inc.
$24
Calyxo, Inc.
$20
Janssen Biotech, Inc.
$16
ABBVIE INC.
$14
Innovation Technologies Inc
$14
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$818
Astellas Pharma US Inc
$500
Dendreon Pharmaceuticals LLC
$375
Teleflex LLC
$332
Janssen Biotech, Inc.
$229
Endo Pharmaceuticals Inc.
$204
Sumitomo Pharma America, Inc.
$198
Myovant Sciences Inc.
$189
Olympus America Inc.
$178
PROCEPT BioRobotics Corporation
$149
Accord Healthcare, Inc.
$144
Avadel Specialty Pharmaceuticals, LLC
$141
Blue Earth Diagnostics Limited
$132
Laborie Medical Technologies Corp.
$121
Photocure Inc
$98
Ferring Pharmaceuticals Inc.
$87
Stryker Corporation
$68
NeoTract Inc.
$66
TherapeuticsMD, Inc.
$64
Merck Sharp & Dohme LLC
$61
NxThera, Inc.
$60
PFIZER INC.
$56
Ambu Inc.
$55
Edap Technomed Inc
$54
BOSTON SCIENTIFIC CORPORATION
$52
180 Medical, Inc.
$49
AbbVie, Inc.
$45
ABBVIE INC.
$42
C. R. Bard, Inc. & Subsidiaries
$41
UROGEN PHARMA, INC.
$38
Amgen Inc.
$26
Axonics, Inc.
$22
Coloplast Corp
$22
KARL STORZ Endoscopy-America
$21
Agiliti Surgical, Inc.
$21
Calyxo, Inc.
$20
Antares Pharma, Inc.
$20
Myriad Genetic Laboratories, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Alnylam Pharmaceuticals Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
AbbVie Inc.
$14
Merck Sharp & Dohme Corporation
$14
Travere Therapeutics, Inc.
$14
Innovation Technologies Inc
$14
Metuchen Pharmaceuticals
$13
Wilmington Medical Supply, Inc.
$13
Retrophin, Inc.
$1
Top 3 companies account for 34.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axumin · BRIDION · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSTO-NEPHRO VIDEOSCOPE · Cysview · ERLEADA · Erleada · FIRMAGON · FLEXIVA · FLUID MANAGEMENT SYSTEM · GEMTESA · GENERAL BPH · GENERAL - THERAPIES · GREENLIGHT · IMVEXXY · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OXLUMO · PROVENGE · Prolaris · Prolia · REZUM · Rezum · Rezum Generator · SPACEOAR · SPACEOAR VUE · Sonablate · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TRICAM · Thiola · UGN Laser Capital · UROLIFT · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
142
Per 100K population
18.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bryant is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bryant experienced with automated urinalysis?
Based on Medicare claims data, Dr. Bryant performed 556 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bryant receive payments from pharmaceutical companies?
Yes. Dr. Bryant received a total of $4,948 from 48 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bryant's costs compare to other urology physicians in Marietta?
Dr. Bryant's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bryant) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Marietta
Browse urology physicians in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology